You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Virus Replication

Showing 1 - 25 of 7,187
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

Enrolling by invitation
  • HIV
  • Antiretroviral Therapy Interruption(ATI)
  • Washington, District of Columbia
  • +1 more
Sep 12, 2022

Viral Replication by Tonate Virus and Zika Virus, Withinex Vivo

Not yet recruiting
  • Zika Virus Infection
  • Cell line and virus
  • +2 more
  • (no location specified)
Oct 17, 2022

Influenza A Trial in Nedlands (CC-42344, Placebo)

Recruiting
  • Influenza A
  • Nedlands, Western Australia, Australia
    Linear Clinical Research
Feb 23, 2022

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • ADVM-043
  • Gainesville, Florida
  • +1 more
Aug 3, 2022

HIV Trial (HIV-1 Immunogen, Structured Treatment Interruption)

Withdrawn
  • HIV Infections
  • HIV-1 Immunogen
  • Structured Treatment Interruption
  • (no location specified)
Oct 28, 2021

Metachromatic Leukodystrophy Trial in Le Kremlin-Bicêtre (intracerebral administration of AAVrh.10cuARSA)

Active, not recruiting
  • Metachromatic Leukodystrophy
  • intracerebral administration of AAVrh.10cuARSA
  • Le Kremlin-Bicêtre, France
    Bicêtre Hospital - Paris Sud
Jan 10, 2022

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Completed
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    Quest Clinical Research
Sep 28, 2021

HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

Active, not recruiting
  • HIV
  • Human Immunodeficiency Virus
  • PRO 140 350mg weekly SQ injection.
  • San Francisco, California
    CD01-Extension Investigational Site
Sep 28, 2021

Vitamin D and Hepatitis B Virus Trial in New Taipei city (Vitamin D)

Completed
Has Results
  • Vitamin D and Hepatitis B Virus
  • Vitamin D
  • New Taipei city, Taiwan
    Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Feb 1, 2020

Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Trial in New York (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies,

Completed
  • Batten Disease
  • Late-Infantile Neuronal Ceroid Lipofuscinosis
  • AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies
  • AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies
  • New York, New York
    Weill Cornell Medical College
Jan 31, 2021

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV Trial in Japan (TBI-1401(HF10), Gemcitabine, Nab-paclitaxel)

Active, not recruiting
  • Pancreatic Cancer Stage III
  • Pancreatic Cancer Stage IV
  • TBI-1401(HF10)
  • +3 more
  • Nagoya, Aichi, Japan
  • +7 more
Mar 31, 2021

Late Infantile Neuronal Ceroid Lipofuscinosis, Batten Disease Trial in New York (AAVrh.10CUCLN2)

Completed
  • Late Infantile Neuronal Ceroid Lipofuscinosis
  • Batten Disease
  • AAVrh.10CUCLN2
  • New York, New York
    Weill Cornell Medical College
Aug 28, 2020

Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

Active, not recruiting
  • Supratentorial Neoplasms, Malignant
  • +6 more
  • G207
  • Birmingham, Alabama
  • +1 more
Jun 1, 2022

Malignant Tumor Trial in Chengdu (Oncolytic Virus SDJ001, Oncolytic Virus YD06-1)

Recruiting
  • Malignant Tumor
  • Oncolytic Virus SDJ001
  • Oncolytic Virus YD06-1
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 6, 2023

Tenofovir Disoproxil Fumarate and Entcavir in Treatment of

Recruiting
  • Chronic Hepatitis b Patients
  • Tenofovir Disoproxil Fumarate and Entcavir
  • Sohag, Egypt
    Sohag University hospitals
May 22, 2023

Analysis of HIV-1 Replication During Antiretroviral Therapy

Enrolling by invitation
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 13, 2023

    Influenza Virus and Coronavirus in Human Brain Explant Culture

    Recruiting
    • Influenza Virus
    • Coronavirus
      • Shatin, NT, Hong Kong
        Prince of Wales Hospital
      Aug 16, 2022

      Persistent SARS-CoV-2 Infection in Cancer and Impaired Immune

      Not yet recruiting
      • Children With Cancer
      • SARS-CoV-2 Infection
        • Cairo, Egypt
          Children's Cancer Hospital Egypt 57357 Cairo, Egypt
        Dec 26, 2021

        Bird Flu, Influenza Trial in United States (Placebo, Ad4-H5-Vtn, Sanofi Pasteur Influenza Virus Vaccine, H5N1)

        Completed
        • Bird Flu
        • Influenza
        • Placebo
        • +2 more
        • Lexington, Kentucky
        • +3 more
        Mar 16, 2020

        Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

        Not yet recruiting
        • Warts
        • Detection of expression of SOCS3 gene
        • +2 more
        • (no location specified)
        Mar 12, 2023

        Batten Disease, Late Infantile Neuronal Ceroid Lipofuscinosis Trial in New York (AAV2CUhCLN2 (3x10^12 particle units))

        Completed
        • Batten Disease
        • Late Infantile Neuronal Ceroid Lipofuscinosis
        • AAV2CUhCLN2 (3x10^12 particle units)
        • New York, New York
          New York Presbyterian Hospital - Weill Medical College of Cornel
        Jul 22, 2020

        Respiratory Syncytial Virus Infections Trial in Baltimore (rRSV A/Maryland/001/11)

        Suspended
        • Respiratory Syncytial Virus Infections
        • rRSV A/Maryland/001/11
        • Baltimore, Maryland
          Johns Hopkins Bloomberg School of Public Health
        Feb 8, 2022